VAERS Explorer
Back to explore

Report #2833677

Received Mar 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (1)

Pain

Symptom narrative

hurts; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: hurts). The outcome of the pain was resolved. The reporter considered the pain to be related to Shingrix. The company considered the pain to be related to Shingrix. Additional Information: GSK Receipt Date: 19-MAR-2025 Pharmacist shared that although patients complain about the first dose hurting more than other vaccines since they usually co-administer Shingrix with other vaccines, patients still return for the second dose. Patients that return for 2nd dose usually states that the second dose was not nearly as bad as the first dose. This was not related to an existing case.